LiTHOS Up-Listed to OTCQB & Announces a Profitable Year

If you have been following LiTHOS than you are aware at the press releases they have issued lately and they are spectacular! Up-Listed to OTCQB Uplisting from OTC to OTCQB is a significant milestone for a publicly traded company. It can provide several benefits, such as: By uplisting to OTCQB, a company can demonstrate its […]
Coeptis Therapeutics Could Revolutionize The Treatment of Cancer

Small Cap Exclusive is proud to present our research report on Coeptis Therapeutics a NASDAQ biopharmaceutical company trading under the ticker (COEP) that is developing innovative treatments in the field of cancer. Take a look at this chart below! There is very little resistance in L2 with market makers and the slightest bit of volume […]